TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Profit & Loss Account Balance History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Profit & Loss Account Balance | ₹5,724 Cr | ₹4,747 Cr | ₹3,942 Cr | ₹3,303 Cr | ₹2,917 Cr |
What is the latest Profit & Loss Account Balance ratio of TORRENT PHARMACEUTICALS ?
| Year | Profit & Loss Account Balance |
|---|---|
| Mar2026 | ₹5,724 Cr |
| Mar2025 | ₹4,747 Cr |
| Mar2024 | ₹3,942 Cr |
| Mar2023 | ₹3,303 Cr |
| Mar2022 | ₹2,917 Cr |
How is Profit & Loss Account Balance of TORRENT PHARMACEUTICALS Trending?
| Years | Profit & Loss Account Balance | % Change | |
|---|---|---|---|
| Mar2026 | ₹5,724 Cr | 20.59 | |
| Mar2025 | ₹4,747 Cr | 20.40 | |
| Mar2024 | ₹3,942 Cr | 19.35 | |
| Mar2023 | ₹3,303 Cr | 13.25 | |
| Mar2022 | ₹2,917 Cr | - | |
Compare Profit & Loss Account Balance of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹154,816.3 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,428.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,426.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| CIPLA | ₹111,604.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,775.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
| MANKIND PHARMA | ₹98,317.8 Cr | 0.9% | -1.2% | 0.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 3.7% |
6.5% |
44.9% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses